A detailed history of Trueblood Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Trueblood Wealth Management, LLC holds 835 shares of LLY stock, worth $664,384. This represents 0.37% of its overall portfolio holdings.

Number of Shares
835
Previous 898 7.02%
Holding current value
$664,384
Previous $813 Million 9.01%
% of portfolio
0.37%
Previous 0.46%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $48,644 - $60,481
-63 Reduced 7.02%
835 $740 Million
Q1 2024

Apr 26, 2024

BUY
$592.2 - $792.28 $60,996 - $81,604
103 Added 12.96%
898 $699 Million
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $417,526 - $492,208
795 New
795 $463 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trueblood Wealth Management, LLC Portfolio

Follow Trueblood Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trueblood Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trueblood Wealth Management, LLC with notifications on news.